Olverembatinib demonstrated activity in patients with CP-CML who received first- or second-generation TKIs as first-line therapy.

Ormat Technologies Inc. (NYSE: ORA), a leading geothermal and renewable energy company, today announced it has successfully ...

Market Overview: The UAE Genetic Testing market is witnessing rapid growth due to increased awareness, advancements in genetic research, and a growing focus on preventive and personalized healthcare.